International gestational age-specific centiles for blood pressure in pregnancy from the INTERGROWTH-21st Project in 8 countries: A longitudinal cohort study.


Journal

PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360

Informations de publication

Date de publication:
04 2021
Historique:
received: 19 12 2020
accepted: 03 04 2021
revised: 11 05 2021
pubmed: 28 4 2021
medline: 12 8 2021
entrez: 27 4 2021
Statut: epublish

Résumé

Gestational hypertensive and acute hypotensive disorders are associated with maternal morbidity and mortality worldwide. However, physiological blood pressure changes in pregnancy are insufficiently defined. We describe blood pressure changes across healthy pregnancies from the International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st) Fetal Growth Longitudinal Study (FGLS) to produce international, gestational age-specific, smoothed centiles (third, 10th, 50th, 90th, and 97th) for blood pressure. Secondary analysis of a prospective, longitudinal, observational cohort study (2009 to 2016) was conducted across 8 diverse urban areas in Brazil, China, India, Italy, Kenya, Oman, the United Kingdom, and the United States of America. We enrolled healthy women at low risk of pregnancy complications. We measured blood pressure using standardised methodology and validated equipment at enrolment at <14 weeks, then every 5 ± 1 weeks until delivery. We enrolled 4,607 (35%) women of 13,108 screened. The mean maternal age was 28·4 (standard deviation [SD] 3.9) years; 97% (4,204/4,321) of women were married or living with a partner, and 68% (2,955/4,321) were nulliparous. Their mean body mass index (BMI) was 23.3 (SD 3.0) kg/m2. Systolic blood pressure was lowest at 12 weeks: Median was 111.5 (95% CI 111.3 to 111.8) mmHg, rising to a median maximum of 119.6 (95% CI 118.9 to 120.3) mmHg at 40 weeks' gestation, a difference of 8.1 (95% CI 7.4 to 8.8) mmHg. Median diastolic blood pressure decreased from 12 weeks: 69.1 (95% CI 68.9 to 69.3) mmHg to a minimum of 68.5 (95% CI 68.3 to 68.7) mmHg at 19+5 weeks' gestation, a change of -0·6 (95% CI -0.8 to -0.4) mmHg. Diastolic blood pressure subsequently increased to a maximum of 76.3 (95% CI 75.9 to 76.8) mmHg at 40 weeks' gestation. Systolic blood pressure fell by >14 mmHg or diastolic blood pressure by >11 mmHg in fewer than 10% of women at any gestational age. Fewer than 10% of women increased their systolic blood pressure by >24 mmHg or diastolic blood pressure by >18 mmHg at any gestational age. The study's main limitations were the unavailability of prepregnancy blood pressure values and inability to explore circadian effects because time of day was not recorded for the blood pressure measurements. Our findings provide international, gestational age-specific centiles and limits of acceptable change to facilitate earlier recognition of deteriorating health in pregnant women. These centiles challenge the idea of a clinically significant midpregnancy drop in blood pressure.

Sections du résumé

BACKGROUND
Gestational hypertensive and acute hypotensive disorders are associated with maternal morbidity and mortality worldwide. However, physiological blood pressure changes in pregnancy are insufficiently defined. We describe blood pressure changes across healthy pregnancies from the International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st) Fetal Growth Longitudinal Study (FGLS) to produce international, gestational age-specific, smoothed centiles (third, 10th, 50th, 90th, and 97th) for blood pressure.
METHODS AND FINDINGS
Secondary analysis of a prospective, longitudinal, observational cohort study (2009 to 2016) was conducted across 8 diverse urban areas in Brazil, China, India, Italy, Kenya, Oman, the United Kingdom, and the United States of America. We enrolled healthy women at low risk of pregnancy complications. We measured blood pressure using standardised methodology and validated equipment at enrolment at <14 weeks, then every 5 ± 1 weeks until delivery. We enrolled 4,607 (35%) women of 13,108 screened. The mean maternal age was 28·4 (standard deviation [SD] 3.9) years; 97% (4,204/4,321) of women were married or living with a partner, and 68% (2,955/4,321) were nulliparous. Their mean body mass index (BMI) was 23.3 (SD 3.0) kg/m2. Systolic blood pressure was lowest at 12 weeks: Median was 111.5 (95% CI 111.3 to 111.8) mmHg, rising to a median maximum of 119.6 (95% CI 118.9 to 120.3) mmHg at 40 weeks' gestation, a difference of 8.1 (95% CI 7.4 to 8.8) mmHg. Median diastolic blood pressure decreased from 12 weeks: 69.1 (95% CI 68.9 to 69.3) mmHg to a minimum of 68.5 (95% CI 68.3 to 68.7) mmHg at 19+5 weeks' gestation, a change of -0·6 (95% CI -0.8 to -0.4) mmHg. Diastolic blood pressure subsequently increased to a maximum of 76.3 (95% CI 75.9 to 76.8) mmHg at 40 weeks' gestation. Systolic blood pressure fell by >14 mmHg or diastolic blood pressure by >11 mmHg in fewer than 10% of women at any gestational age. Fewer than 10% of women increased their systolic blood pressure by >24 mmHg or diastolic blood pressure by >18 mmHg at any gestational age. The study's main limitations were the unavailability of prepregnancy blood pressure values and inability to explore circadian effects because time of day was not recorded for the blood pressure measurements.
CONCLUSIONS
Our findings provide international, gestational age-specific centiles and limits of acceptable change to facilitate earlier recognition of deteriorating health in pregnant women. These centiles challenge the idea of a clinically significant midpregnancy drop in blood pressure.

Identifiants

pubmed: 33905424
doi: 10.1371/journal.pmed.1003611
pii: PMEDICINE-D-20-06147
pmc: PMC8112691
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1003611

Subventions

Organisme : Department of Health
Pays : United Kingdom

Déclaration de conflit d'intérêts

I have read the journal’s policy and the authors of this manuscript have the following competing interests: PW holds grants from the National Institute for Health Research; LM and AP are supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC). SG is funded by an NIHR Doctoral Research Fellowship (DRF-2016-09-073). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. LM works part-time for Sensyne Health. PW worked for Sensyne Health. Both have share options in Sensyne Health; ZB is a member of the Editorial Board of PLOS Medicine; no other relationships or activities that could appear to have influenced the submitted work.

Références

Obstet Gynecol. 2020 Mar;135(3):653-664
pubmed: 32028507
BJOG. 2013 Sep;120 Suppl 2:71-6, v
pubmed: 23679843
Lancet Diabetes Endocrinol. 2014 Oct;2(10):781-92
pubmed: 25009082
PLoS Med. 2014 Jul 08;11(7):e1001672
pubmed: 25003759
Food Nutr Bull. 2004 Mar;25(1 Suppl):S5-14
pubmed: 15069915
Hypertension. 2018 Jul;72(1):24-43
pubmed: 29899139
J Hypertens. 2011 Apr;29(4):763-8
pubmed: 21178781
J Hypertens. 2015 Jan;33(1):96-105
pubmed: 25255393
BJOG. 2013 Sep;120 Suppl 2:42-7, v
pubmed: 23841804
J Hypertens. 2014 Apr;32(4):849-56
pubmed: 24406777
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Resuscitation. 2019 Jan;134:147-156
pubmed: 30287355
Sci Rep. 2017 Jul 24;7(1):6227
pubmed: 28740155
BJOG. 2019 Feb;126(3):383-392
pubmed: 29782079
Sci Transl Med. 2015 Aug 5;7(299):299ra122
pubmed: 26246167
Clin Sci. 1969 Oct;37(2):395-407
pubmed: 5358998
Am J Hypertens. 2013 Jan;26(1):141-8
pubmed: 23382338
BJOG. 2013 Sep;120 Suppl 2:9-26, v
pubmed: 23678873
Anaesthesia. 2014 Jul;69(7):687-92
pubmed: 24801160
Lancet. 2014 Sep 6;384(9946):869-79
pubmed: 25209488
Acta Obstet Gynecol Scand. 2001 Sep;80(9):824-9
pubmed: 11531633
J Hypertens. 2010 Nov;28(11):2210-8
pubmed: 20724938
Am J Med. 1980 Jan;68(1):97-104
pubmed: 7350810
BMC Med. 2019 Sep 11;17(1):167
pubmed: 31506067

Auteurs

Lauren J Green (LJ)

Critical Care Research Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford University Hospitals NHS Trust, NIHR Biomedical Research Centre, Oxford, United Kingdom.

Stephen H Kennedy (SH)

Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom.
Oxford Maternal & Perinatal Health Institute, Green Templeton College, University of Oxford, Oxford, United Kingdom.

Lucy Mackillop (L)

Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom.

Stephen Gerry (S)

Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.

Manorama Purwar (M)

Nagpur INTERGROWTH-21st Research Centre, Ketkar Hospital, Nagpur, India.

Eleonora Staines Urias (E)

Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom.

Leila Cheikh Ismail (L)

Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom.
College of Health Sciences, University of Sharjah, United Arab Emirates.

Fernando Barros (F)

Programa de Pós-Graduação em Saúde e Comportamento, Universidade Católica de Pelotas, Pelotas, Brazil.

Cesar Victora (C)

Programa de Pós-Graduação em Epidemiologia, Universidade Federal de Pelotas, Pelotas, Brazil.

Maria Carvalho (M)

Faculty of Health Sciences, Aga Khan University, Nairobi, Kenya.

Eric Ohuma (E)

Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom.
Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.
Centre for Global Child Health, Hospital for Sick Children, Toronto, Canada.

Yasmin Jaffer (Y)

Department of Family & Community Health, Ministry of Health, Muscat, Sultanate of Oman.

J Alison Noble (JA)

Department of Engineering Science, University of Oxford, Oxford, United Kingdom.

Michael Gravett (M)

Departments of Obstetrics and Gynecology and of Global Health, University of Washington, Seattle, Washington, United States of America.

Ruyan Pang (R)

School of Public Health, Peking University, Beijing, China.

Ann Lambert (A)

Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom.

Enrico Bertino (E)

Dipartimento di Scienze Pediatriche e dell' Adolescenza, SCDU Neonatologia, Universita di Torino, Torino, Italy.

Aris T Papageorghiou (AT)

Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom.
Oxford Maternal & Perinatal Health Institute, Green Templeton College, University of Oxford, Oxford, United Kingdom.

Cutberto Garza (C)

Division of Nutritional Sciences, Cornell University, Ithaca, New York, United States of America.

Zulfiqar Bhutta (Z)

Centre for Global Child Health, Hospital for Sick Children, Toronto, Canada.

José Villar (J)

Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, United Kingdom.
Oxford Maternal & Perinatal Health Institute, Green Templeton College, University of Oxford, Oxford, United Kingdom.

Peter Watkinson (P)

Critical Care Research Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford University Hospitals NHS Trust, NIHR Biomedical Research Centre, Oxford, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH